Watchdog unsure GPhC would have improved ‘timeliness’ of FtP cases without pandemic

The General Pharmaceutical Council’s (GPhC) timeliness in progressing fitness-to-practise (FtP) cases declined “significantly” in 2020/21 and it is unclear “whether it would have improved without the pandemic”, the Professional Standards Authority (PSA) has said.